Home > Insider Trading > Filing (0001225208-17-019019)

Filing Details

Accession Number:: 0001225208-17-019019
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-12-22 14:57:38
Reporting Period:: 2017-12-20

Accepted Time:: 2017-12-22 14:57:38
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
9892	Bard C R Inc	BCR	Surgical & Medical Instruments & Apparatus (3841)	221454160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1403373	A John Deford	C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974	Sr. Vp Sci Tech And Clin Afrs	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-12-20	4,161	$136.37	20,950	No	4	M	Direct
Common Stock	Acquisiton	2017-12-20	3,767	$168.87	24,717	No	4	M	Direct
Common Stock	Acquisiton	2017-12-20	3,293	$186.43	28,010	No	4	M	Direct
Common Stock	Acquisiton	2017-12-20	2,886	$219.56	30,896	No	4	M	Direct
Common Stock	Disposition	2017-12-20	900	$334.12	29,996	No	4	S	Direct
Common Stock	Disposition	2017-12-20	13,207	$333.43	16,789	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to Buy)	Disposition	2017-12-20	3,293	$0.00	3,293	$186.43
Common Stock	Option (Right to Buy)	Disposition	2017-12-20	3,767	$0.00	3,767	$168.87
Common Stock	Option (Right to Buy)	Disposition	2017-12-20	4,161	$0.00	4,161	$136.37
Common Stock	Option (Right to Buy)	Disposition	2017-12-20	2,886	$0.00	2,886	$219.56

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,586	2025-12-09	No	4	M	Direct
3,768	2024-12-10	No	4	M	Direct
0	2023-12-11	No	4	M	Direct
8,658	2026-12-14	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	84	Indirect	401(k) Plan

Footnotes

Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan.
Includes 0.0887 shares acquired under the Company's Dividend Reinvestment Plan from February 4, 2017 to August 4, 2017. Includes 0.0020 shares acquired under the Company's Employee Stock Purchase Plan from February 7, 2017 to August 7, 2017.
Represents the weighted average sales price for price increments ranging from $333.97 to $334.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Represents the weighted average sales price for price increments ranging from $332.96 to $333.95. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 3.904 shares acquired under the Company's 401(k) Plan from May 4, 2017 to August 4, 2017.
Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated).
Of this option grant 3,293 options vested on December 9, 2017 and the remaining options vest in two annual installments beginning on December 9, 2018.
Of this option grant 3,767 options vested on December 10, 2017 and the remaining options vest on December 10, 2018.
Options vested on December 11, 2017.
Of this option grant 2,886 options vested on December 14, 2017 and the remaining options vest in three annual installments beginning on December 14, 2018.